Development and Validation of a Bioanalytical UHPLC-MS/MS Method Applied to Murine Liver Tissue for the Determination of Indocyanine Green Loaded in H-Ferritin Nanoparticles

Indocyanine green (ICG) is one of the most commonly used fluorophores in near-infrared fluorescence-guided techniques. However, the molecule is prone to form aggregates in saline solution with a limited photostability and a moderate fluorescence yield. ICG was thus formulated using protein-based nanoparticles of H-ferritin (HFn) in order to generate a new nanostructure, HFn-ICG. In this study, an ultrahigh performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) system was employed to develop and validate the quantitative analysis of ICG in liver tissue samples from HFn-ICG-treated mice. To precipitate HFn, cold acetone in acidic solution at pH 5.0 was used. The processed liver samples were injected into the UHPLC-MS/MS system for analysis using the positive electrospray ionization mode. Chromatographic separation was achieved on a Waters Acquity UPLC® HSS T3 Column (1.8 μm, 2.1 × 100 mm) with 0.1% formic acid and acetonitrile as the mobile phase with gradient elution. The selected reaction monitoring transitions of m / z 753 → m / z 330 and m / z 827 → m / z 330 were applied for ICG and IR-820 (the internal standard, IS), respectively. The method was selective and linear over a concentration range of 50–1,500 ng/ml. The method was validated for sensitivity, accuracy, precision, extraction recovery, matrix effect, and stability in liver tissue homogenates. ICG extraction recoveries ranged between 85 and 108%. The intra- and inter-day precisions were less than 6.28%. The method was applied to a bio-distribution study to compare the amount of ICG levels from mice treated with HFn-ICG and free ICG. The analyses of the homogenate samples from the two types of treatment showed that the concentration levels of ICG is approximately six-fold higher than those of free ICG (1,411 ± 7.62 ng/ml vs. 235 ± 26.0 ng/ml) at 2 h post injection.

[1]  S. Mazzucchelli,et al.  Tumor Accumulation and Off-Target Biodistribution of an Indocyanine-Green Fluorescent Nanotracer: An Ex Vivo Study on an Orthotopic Murine Model of Breast Cancer , 2021, International journal of molecular sciences.

[2]  S. Mazzucchelli,et al.  Development and validation of a simple and versatile method for the quantification of everolimus loaded in H-ferritin nanocages using UHPLC-MS/MS. , 2020, Journal of pharmaceutical and biomedical analysis.

[3]  S. Mazzucchelli,et al.  Indocyanine Green Nanoparticles: Are They Compelling for Cancer Treatment? , 2020, Frontiers in Chemistry.

[4]  C. Morasso,et al.  Development of Tumor-Targeted Indocyanine Green-Loaded Ferritin Nanoparticles for Intraoperative Detection of Cancers , 2020, ACS omega.

[5]  G. Dolivet,et al.  NIR fluorescence-guided tumor surgery: new strategies for the use of indocyanine green , 2019, International journal of nanomedicine.

[6]  Neelkanth M. Bardhan,et al.  Deep-tissue optical imaging of near cellular-sized features , 2019, Scientific Reports.

[7]  Z. Dai,et al.  Doxorubicin and indocyanine green loaded superparamagnetic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma , 2018, International journal of nanomedicine.

[8]  Zbigniew Starosolski,et al.  NIR-II fluorescence imaging using indocyanine green nanoparticles , 2018, Scientific Reports.

[9]  M. Neumaier,et al.  Stability and degradation of indocyanine green in plasma, aqueous solution and whole blood , 2018, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[10]  W. Petz,et al.  Green indocyanine fluorescence in robotic abdominal surgery , 2018, Updates in Surgery.

[11]  Feng Gao,et al.  Assessing indocyanine green pharmacokinetics in mouse liver with a dynamic diffuse fluorescence tomography system , 2018, Journal of biophotonics.

[12]  G. Franceschini,et al.  New techniques for sentinel node biopsy in breast cancer , 2018 .

[13]  M. Roberts,et al.  Indocyanine green-incorporating nanoparticles for cancer theranostics , 2018, Theranostics.

[14]  B. Heniford,et al.  Indocyanine Green , 2016, Surgical innovation.

[15]  G. Lin,et al.  Pharmacokinetic study of indocyanine Green after intravenous administration by UPLC-MS/MS. , 2015, International journal of clinical and experimental medicine.

[16]  M. Bellini,et al.  Protein nanocages for self-triggered nuclear delivery of DNA-targeted chemotherapeutics in Cancer Cells. , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[17]  A. D. Rodrigues,et al.  A liquid chromatography tandem mass spectrometry method for the quantification of indocyanine green in dog plasma and bile. , 2008, Journal of pharmaceutical and biomedical analysis.

[18]  B. Matuszewski,et al.  Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. , 2003, Analytical chemistry.

[19]  T. Desmettre,et al.  Fluorescence properties and metabolic features of indocyanine green (ICG) as related to angiography. , 2000, Survey of ophthalmology.